Related Articles

News
STAT+: Kite to buy Tmunity Therapeutics, Carl June’s troubled CAR-T startup
December 20, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Kite to buy Tmunity Therapeutics, Carl June’s troubled CAR-T startup
Kite’s two recent deals represent notable investments in a type of CAR-T that some had thought may become obsolete. […]

News
STAT+: How one private biotech seized on JPM to emerge from stealth and tell its story
January 23, 2023
San Francisco Biotechnology Network News
News
Comments Off on STAT+: How one private biotech seized on JPM to emerge from stealth and tell its story
Out of stealth, Rezo Therapeutics seized on #JPM23 to tell its story. […]

News
STAT+: PACT Pharma’s personalized cancer treatments, powered by CRISPR, clear early safety hurdles
November 10, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: PACT Pharma’s personalized cancer treatments, powered by CRISPR, clear early safety hurdles
PACT Pharma and UCLA researchers infused individualized cocktails of CRISPR-edited immune cells into 16 cancer patients with minimal and manageable side effects. […]